Invention Publication
- Patent Title: DIACYLGLYCEROL KINASE MODULATING COMPOUNDS
-
Application No.: US18450646Application Date: 2023-08-16
-
Publication No.: US20240182476A1Publication Date: 2024-06-06
- Inventor: Masaaki Sawa , Mai Arai , Ryoko Nakai , Hirokazu Matsumoto , Catherine Pugh , Eric Hu , Juan Guerrero , Jesse Jacobsen , Jonathan William Medley , Jie Xu , Latesh Lad , Leena Patel , Michael Graupe , Qingming Zhu , Stephen Holmbo , Tetsuya Kobayashi , Will Watkins , Yasamin Moazami , Suet C. Yeung , Julian A. Codelli , Heath A. Weaver
- Applicant: GILEAD SCIENCES, INC. , CARNA BIOSCIENCES, INC.
- Applicant Address: US CA Foster City
- Assignee: GILEAD SCIENCES, INC.,CARNA BIOSCIENCES, INC.
- Current Assignee: GILEAD SCIENCES, INC.,CARNA BIOSCIENCES, INC.
- Current Assignee Address: US CA Foster City
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/395 ; A61K31/519 ; A61K31/5377 ; A61K31/538 ; A61K31/55 ; A61K31/553 ; A61K31/695 ; A61K31/704 ; A61K31/7068 ; A61K35/15 ; A61K35/17 ; A61K39/395 ; A61K45/06 ; C07D519/00 ; C07F7/18
Abstract:
The present disclosure provides diacylglycerol kinase modulating compounds, and pharmaceutical compositions thereof, for treating cancer, including solid tumors, and viral infections, such as HIV or hepatitis B virus infection. The compounds can be used alone or in combination with other agents.
Public/Granted literature
- US12054490B2 Diacylglycerol kinase modulating compounds Public/Granted day:2024-08-06
Information query
